TP53 and head and neck squamous cell carcinoma: In a pivotal study by Wang et al. involving 93 patients with HNSCC, both plasma and saliva samples were analyzed to identify somatic mutations (TP53, PIK3CA, CDKN2A, HRAS, NRAS) and HPV serotypes (HPV-16, -18) [40].